Study: Bone-building drug blocks effects of steroids
Wednesday, April 15, 2009
A Novartis-funded study found that a once-yearly injection of bone-building treatment Reclast was more effective than a daily dose of the oral bisphosphonate pill Actonel in reversing bone loss in patients who are taking glucocorticoid drugs to treat immune-related conditions, such as asthma and lupus. The study's lead author said he is optimistic that Reclast would get FDA approval to treat patients taking steroids.
On the go?
Text INFO to 50555 and opt-in to receive breaking news about lupus on your mobile phone.
Message and Data Rates May Apply. Text STOP to 50555 to STOP. Text HELP to 50555 for HELP. Full Terms